SOLARAPharmaceuticals
Solara Active Pharma Sciences Ltd — PE Ratio & Valuation Analysis
₹425.55
-3.05%
Current P/E361.52xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E4035.4x91.0% below avg
⚠️
1037.9% Premium to Industry
SOLARA P/E 361.52x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹0.14 | ₹565 | 4035.4x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Solara Active Pharma Sciences Ltd Valuation
Solara Active Pharma Sciences Ltd (SOLARA) currently trades at 361.52x earnings. The Pharmaceuticals sector average PE is 31.77x. SOLARA commands a premium, reflecting high growth expectations. Historically, SOLARA has traded at an average PE of 4035.4x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
0.05%
Dividend Yield
0.00%
More on Solara Active Pharma Sciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.